197 related articles for article (PubMed ID: 27159079)
1. Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.
Zhao Y; Detering L; Sultan D; Cooper ML; You M; Cho S; Meier SL; Luehmann H; Sun G; Rettig M; Dehdashti F; Wooley KL; DiPersio JF; Liu Y
ACS Nano; 2016 Jun; 10(6):5959-70. PubMed ID: 27159079
[TBL] [Abstract][Full Text] [Related]
2. ⁶⁴Cu-Doped PdCu@Au Tripods: A Multifunctional Nanomaterial for Positron Emission Tomography and Image-Guided Photothermal Cancer Treatment.
Pang B; Zhao Y; Luehmann H; Yang X; Detering L; You M; Zhang C; Zhang L; Li ZY; Ren Q; Liu Y; Xia Y
ACS Nano; 2016 Mar; 10(3):3121-31. PubMed ID: 26824412
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
Weiss ID; Jacobson O; Kiesewetter DO; Jacobus JP; Szajek LP; Chen X; Farber JM
Mol Imaging Biol; 2012 Feb; 14(1):106-14. PubMed ID: 21347799
[TBL] [Abstract][Full Text] [Related]
4. Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.
Zhao Y; Sultan D; Detering L; Luehmann H; Liu Y
Nanoscale; 2014 Nov; 6(22):13501-9. PubMed ID: 25266128
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall [(64)Cu]Cu nanoclusters for targeting orthotopic lung tumors using accurate positron emission tomography imaging.
Gao F; Cai P; Yang W; Xue J; Gao L; Liu R; Wang Y; Zhao Y; He X; Zhao L; Huang G; Wu F; Zhao Y; Chai Z; Gao X
ACS Nano; 2015 May; 9(5):4976-86. PubMed ID: 25919205
[TBL] [Abstract][Full Text] [Related]
6.
Burke BP; Miranda CS; Lee RE; Renard I; Nigam S; Clemente GS; D'Huys T; Ruest T; Domarkas J; Thompson JA; Hubin TJ; Schols D; Cawthorne CJ; Archibald SJ
J Nucl Med; 2020 Jan; 61(1):123-128. PubMed ID: 31201250
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.
Nimmagadda S; Pullambhatla M; Stone K; Green G; Bhujwalla ZM; Pomper MG
Cancer Res; 2010 May; 70(10):3935-44. PubMed ID: 20460522
[TBL] [Abstract][Full Text] [Related]
9. 64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.
Jacobson O; Weiss ID; Szajek L; Farber JM; Kiesewetter DO
Bioorg Med Chem; 2009 Feb; 17(4):1486-93. PubMed ID: 19188071
[TBL] [Abstract][Full Text] [Related]
10. CXCR4-targeted PET imaging using
Muz B; Bandara N; Mpoy C; Sun J; Alhallak K; Azab F; Rogers BE; Azab AK
Cancer Biol Ther; 2020; 21(1):52-60. PubMed ID: 31571524
[No Abstract] [Full Text] [Related]
11. Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.
Heo GS; Zhao Y; Sultan D; Zhang X; Detering L; Luehmann HP; Zhang X; Li R; Choksi A; Sharp S; Levingston S; Primeau T; Reichert DE; Sun G; Razani B; Li S; Weilbaecher KN; Dehdashti F; Wooley KL; Liu Y
ACS Appl Mater Interfaces; 2019 Jun; 11(22):19669-19678. PubMed ID: 31074257
[TBL] [Abstract][Full Text] [Related]
12. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.
Gourni E; Demmer O; Schottelius M; D'Alessandria C; Schulz S; Dijkgraaf I; Schumacher U; Schwaiger M; Kessler H; Wester HJ
J Nucl Med; 2011 Nov; 52(11):1803-10. PubMed ID: 22045709
[TBL] [Abstract][Full Text] [Related]
13. Effect of a nitric oxide synthase inhibitor and a CXC chemokine receptor-4 antagonist on tumor growth and metastasis in a xenotransplanted mouse model of adenoid cystic carcinoma of the oral floor.
Takaoka K; Hidaka S; Hashitani S; Segawa E; Yamamura M; Tanaka N; Zushi Y; Noguchi K; Kishimoto H; Urade M
Int J Oncol; 2013 Sep; 43(3):737-45. PubMed ID: 23835861
[TBL] [Abstract][Full Text] [Related]
14. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 antagonists suppress small cell lung cancer progression.
Taromi S; Kayser G; Catusse J; von Elverfeldt D; Reichardt W; Braun F; Weber WA; Zeiser R; Burger M
Oncotarget; 2016 Dec; 7(51):85185-85195. PubMed ID: 27835905
[TBL] [Abstract][Full Text] [Related]
16. C-X-C Chemokine Receptor Type 4-Targeted Imaging in Glioblastoma Multiforme Using
Zhang X; Detering L; Sultan D; Heo GS; Luehmann H; Taylor S; Choksi A; Rubin JB; Liu Y
ACS Appl Bio Mater; 2022 Jan; 5(1):235-242. PubMed ID: 35014818
[TBL] [Abstract][Full Text] [Related]
17. Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
Cao Q; Cai W; Niu G; He L; Chen X
Clin Cancer Res; 2008 Oct; 14(19):6137-45. PubMed ID: 18829492
[TBL] [Abstract][Full Text] [Related]
18. Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy.
Zhao Y; Sultan D; Detering L; Cho S; Sun G; Pierce R; Wooley KL; Liu Y
Angew Chem Int Ed Engl; 2014 Jan; 53(1):156-9. PubMed ID: 24272951
[TBL] [Abstract][Full Text] [Related]
19. A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.
Azad BB; Chatterjee S; Lesniak WG; Lisok A; Pullambhatla M; Bhujwalla ZM; Pomper MG; Nimmagadda S
Oncotarget; 2016 Mar; 7(11):12344-58. PubMed ID: 26848769
[TBL] [Abstract][Full Text] [Related]
20. Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[
Hartimath SV; Draghiciu O; Daemen T; Nijman HW; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2020 Aug; 22(4):883-890. PubMed ID: 31802362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
